Opinion: Survey: Neurologists split on prescribing new Alzheimer’s treatments
STAT
JULY 28, 2024
As more than 7,500 clinicians and researchers converge in Philadelphia for the Alzheimer’s Association International Conference , a sharp division is emerging over new treatments for the disease that brings them together each year. This divide is over when to prescribe one of the newer drugs to treat Alzheimer’s disease. Lecanemab (Leqembi) was approved by the U.S.
Let's personalize your content